blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3347013

EP3347013 - NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR FOR TREATMENT OF ATTENTION DEFICIT DISORDER [Right-click to bookmark this link]
Former [2018/29]NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME
[2021/11]
StatusNo opposition filed within time limit
Status updated on  23.12.2022
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  14.01.2022
FormerGrant of patent is intended
Status updated on  04.10.2021
FormerExamination is in progress
Status updated on  09.07.2021
FormerGrant of patent is intended
Status updated on  10.03.2021
FormerExamination is in progress
Status updated on  05.04.2020
FormerRequest for examination was made
Status updated on  15.06.2018
FormerThe international publication has been made
Status updated on  21.03.2017
Most recent event   Tooltip31.05.2024Lapse of the patent in a contracting state
New state(s): MK		published on 03.07.2024  [2024/27]
Applicant(s)For all designated states
The Children's Hospital of Philadelphia
3401 Civic Center Boulevard
Philadelphia, PA 19104 / US
[2018/29]
Inventor(s)01 / HAKONARSON, Hakon
1877 Covered Bridge Road
Malvern, Pennsylvania 19355 / US
02 / KAO, Charlly
4619 Chester Avenue
Apt B202
Philadelphia, Pennsylvania 19143 / US
 [2021/32]
Former [2018/29]01 / HAKONARSON, Hakon
1877 Covered Bridge Road
Malvern, Pennsylvania 19355 / US
02 / KAO, Charlly
4601 Chester Avenue
Apt 2D
Philadelphia, Pennsylvania 19143 / US
Representative(s)Høiberg P/S
Adelgade 12
1304 Copenhagen K / DK
[2018/29]
Application number, filing date16767112.207.09.2016
[2018/29]
WO2016US50559
Priority number, dateUS201562215628P08.09.2015         Original published format: US 201562215628 P
US201562215633P08.09.2015         Original published format: US 201562215633 P
US201562215636P08.09.2015         Original published format: US 201562215636 P
US201562215673P08.09.2015         Original published format: US 201562215673 P
[2018/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017044491
Date:16.03.2017
Language:EN
[2017/11]
Type: A1 Application with search report 
No.:EP3347013
Date:18.07.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 16.03.2017 takes the place of the publication of the European patent application.
[2018/29]
Type: B1 Patent specification 
No.:EP3347013
Date:16.02.2022
Language:EN
[2022/07]
Search report(s)International search report - published on:EP16.03.2017
ClassificationIPC:A61K31/454, A61P25/00, A61P25/28
[2018/29]
CPC:
A61K31/454 (EP,CN,IL,US); A61K45/06 (EP,IL,US); A61P25/00 (CN,IL);
A61P25/14 (IL); A61P25/22 (EP,IL); A61P25/28 (CN,IL);
A61P43/00 (IL); C12Q1/6883 (IL,US); A61K2300/00 (IL);
C12Q2600/156 (IL,US); C12Q2600/158 (IL,US) (-)
C-Set:
A61K31/454, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/29]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:NICHT-SELEKTIVER METABOTROPER GLUTAMATREZEPTORAKTIVATOR ZUR BEHANDLUNG VON AUFMERKSAMKEITSDEFIZITSYNDROM[2021/11]
English:NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR FOR TREATMENT OF ATTENTION DEFICIT DISORDER[2021/11]
French:ACTIVATEUR DU RÉCEPTEUR MÉTABOTROPIQUE DU GLUTAMATE NON SÉLECTIF POUR LE TRAITEMENT DU TROUBLE DÉFICITAIRE DE L'ATTENTION[2021/11]
Former [2018/29]NICHT-SELEKTIVE METABOTROPE GLUTAMATREZEPTORAKTIVATOREN ZUR BEHANDLUNG VON AUFMERKSAMKEITSDEFIZITSYNDROM UND 22Q-SYNDROM
Former [2018/29]NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ATTENTION DEFICIT DISORDER AND 22Q SYNDROME
Former [2018/29]ACTIVATEURS DU RÉCEPTEUR MÉTABOTROPIQUE DU GLUTAMATE NON SÉLECTIFS POUR LE TRAITEMENT DU TROUBLE DÉFICITAIRE DE L'ATTENTION ET DU SYNDROME 22Q
Entry into regional phase05.04.2018National basic fee paid 
05.04.2018Designation fee(s) paid 
05.04.2018Examination fee paid 
Examination procedure05.04.2018Examination requested  [2018/29]
05.04.2018Date on which the examining division has become responsible
14.11.2018Amendment by applicant (claims and/or description)
08.04.2020Despatch of a communication from the examining division (Time limit: M02)
18.06.2020Reply to a communication from the examining division
11.03.2021Communication of intention to grant the patent
07.07.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
05.10.2021Communication of intention to grant the patent
11.01.2022Fee for grant paid
11.01.2022Fee for publishing/printing paid
11.01.2022Receipt of the translation of the claim(s)
Divisional application(s)EP22156141.8  / EP4023222
Opposition(s)17.11.2022No opposition filed within time limit [2023/04]
Fees paidRenewal fee
25.09.2018Renewal fee patent year 03
13.09.2019Renewal fee patent year 04
14.09.2020Renewal fee patent year 05
13.09.2021Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.09.2016
AL16.02.2022
AT16.02.2022
CY16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
MK16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
[2024/27]
Former [2024/21]HU07.09.2016
AL16.02.2022
AT16.02.2022
CY16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2024/18]HU07.09.2016
AL16.02.2022
AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/22]AL16.02.2022
AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
MC16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/10]AL16.02.2022
AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SI16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2023/01]AL16.02.2022
AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/49]AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SK16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/48]AT16.02.2022
CZ16.02.2022
EE16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/47]AT16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RO16.02.2022
RS16.02.2022
SE16.02.2022
SM16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/42]AT16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
IS17.06.2022
Former [2022/39]AT16.02.2022
FI16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
Former [2022/36]AT16.02.2022
HR16.02.2022
LT16.02.2022
LV16.02.2022
NL16.02.2022
PL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
GR17.05.2022
PT16.06.2022
Former [2022/35]HR16.02.2022
LT16.02.2022
NL16.02.2022
RS16.02.2022
SE16.02.2022
BG16.05.2022
NO16.05.2022
PT16.06.2022
Former [2022/34]LT16.02.2022
NL16.02.2022
NO16.05.2022
PT16.06.2022
Former [2022/33]LT16.02.2022
NO16.05.2022
Cited inInternational search[XI]US2013203814  (GLESSNER JOSEPH [US], et al);
 [A]US2013225623  (BUXBAUM JOSEPH [US], et al);
by applicantWO2012027491
 US2013203814
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.